179eP NGAL and traditional biomarkers in cervical cancer: A comparative evaluation using random forest
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Accurately predicting chemoradiotherapy response is essential to improving patient outcomes, as cervical cancer continues to be a significant worldwide health burden. Finding trustworthy biomarkers could allow for earlier risk assessment and precise treatment.
Fields of Study & Subjects
Endometrial and Cervical Cancer Treatments
Inflammatory Biomarkers in Disease Prognosis
Cervical Cancer and HPV Research
Publication details
- Journal / source
- ESMO Open
- Volume
- 11
- Pages
- 106186–106186
- Publication date
- 1 April 2026
- Language
- EN